April 25, 2024
Now available ANKTIVA®
ANKTIVA® (nogapendekin alfa inbakicept-pmln) is an interleukin-15 (IL-15) receptor agonist indicated with Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCG- unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.